A tiny hearing aid you can test at CES — Ceretone brings the Core One Pro to Las Vegas

This article was written by the Augury Times
Ceretone invites CES visitors to try the Core One Pro in person
Ceretone is debuting its Core One Pro hearing aid at CES 2026 in Las Vegas and is asking show attendees to try the device on the spot. The company’s release pitches the Core One Pro as a tiny, almost hidden over‑the‑counter (OTC) hearing aid meant for everyday use, and it will be on display at Booth #54619. Attendees can get a free quick hearing check and a hands‑on demo during the show.
What Ceretone says about the Core One Pro’s design and tech
According to the company, the Core One Pro is built to be as small and discreet as possible — the release describes it as roughly the size of a penny and able to sit largely inside the ear canal so it’s minimally visible. Ceretone highlights a light, comfortable shell made from skin‑friendly materials and multiple soft tip sizes to fit different ears.
The company frames the device as rechargeable rather than single‑use, and it says the battery will last through normal daily wear between charging sessions. It also points to on‑device signal processing: digital noise suppression and adaptive sound processing that the company says helps focus on speech while reducing background noise. Ceretone also emphasizes tuning options — either preprogrammed profiles or on‑device adjustments — to let users tailor the sound to their comfort.
Those engineering notes are presented as selling points in the release: a tiny mechanical design, compact electronics and what the company calls “advanced low‑power audio processing” so the unit can be small without giving up sound quality. All of those claims are framed as company statements rather than independently verified results.
How the CES demos and testing will work
Ceretone’s booth will offer complimentary, quick hearing checks for attendees and live demos of the Core One Pro. The typical flow the company describes: stop by Booth #54619, have a short screening with staff, try a demo unit fitted with the size of tip that feels right, and listen through a simple demo routine that highlights speech in noisy and quiet settings.
Staff at the booth should be available throughout exhibit hours, and the company recommends reserving a slot through the CES exhibitor tools or by visiting the booth to avoid long waits. The setup is aimed at giving people a direct sense of the fit and sound rather than replacing a full clinical assessment.
How Core One Pro fits into the growing OTC hearing‑aid market
The Core One Pro is arriving into a consumer market that has changed a lot since regulators approved over‑the‑counter hearing aids: manufacturers now sell directly to consumers without a prescription, and products range from simple sound amplifiers to fully featured devices with app control and noise processing. Typical buyers look for a low‑friction way to address mild to moderate hearing issues without visiting an audiologist.
Competitors in this space include long‑standing hearing companies that have launched consumer lines, newer startups focused on direct sales, and large consumer brands that pair simple hearing devices with wellness offerings. Pricing in the OTC category varies widely — some devices undercut traditional clinic prices by a lot while others aim for premium margins with extra features and services. The Core One Pro appears aimed at people who want a discreet, tech‑forward option that they can try immediately and use without a clinic visit.
Company messaging and what the press release doesn’t answer
Ceretone’s release presents the Core One Pro as nearly invisible and easy to use, and it stresses the demo and free screening at CES. Those are clear marketing points. What the release leaves out — or doesn’t fully detail — are items buyers usually want to know: specific battery life in hours, precise water or sweat resistance ratings, a clear price and retail availability timeline, warranty and return policies, and the extent of any clinical testing or independent validation of hearing benefit.
In short, the release makes product claims but stops short of publishing the data and policies that show how the device performs in real life and how customers are protected after purchase.
Practical next steps if you want to see Core One Pro at CES
To try the Core One Pro, head to Booth #54619 at CES in Las Vegas during exhibit hours and ask about the free screening and demo. If you can’t attend, watch for hands‑on reviews from independent journalists after the show — that’s when you’ll start to see comparisons, real‑world battery tests and more detail on pricing and return terms. Ceretone’s booth staff will handle media inquiries on site, and the company says broader retail availability will be announced after CES.
Sources
Comments
More from Augury Times
Agilent move could bring Wasatch’s targeted methylation test into more labs — what investors should watch
Wasatch BioLabs and Agilent agreed to co-market a native-read direct targeted methylation sequencing (dTMS) test. The deal could speed lab adoption but offers modest near-term reve…

FTC Steps Up Against No‑Hire Pacts — What Employers and Investors Need to Know
The FTC has moved again to block no‑hire and no‑poach deals. Here’s what the new action requires, why it matters for wages and margins, and what companies and investors should watc…

ECB wage tracker points to cooling pay pressures — markets brace for a gentler 2026 normalisation
The ECB’s new wage tracker shows slower pay growth and easing negotiated wage deals, nudging markets toward a softer 2026 rate path. Here’s what investors should watch.…
How fragmentation is quietly shaving billions from tokenized assets — and what investors should do about it
A new study estimates fragmentation across chains and trading venues takes up to $1.3B a year from tokenized assets. Here’s how the model works, why it matters for price discovery…

Augury Times

Lawsuit Ties Jump Trading to Terra’s $50B Collapse — $4B Claim Raises New Questions for Market Makers
A $4 billion lawsuit accuses Jump Trading of profiting from the 2022 Terra stablecoin collapse. Here’s what the…

Law Firm Files Suit Against Coupang — Investors Urged to Consider Joining Class Over Alleged Misstatements
Bronstein, Gewirtz & Grossman says a class action has been filed against Coupang (CPNG) alleging investor harm. What…

A House Divided: Bitcoin Traders Brace for Either a Deep Pullback or a Fast Return to the Highs
Bitcoin (BTC) traders are split between a risky slide toward $70K and a quick rebound. Read a clear, neutral guide to…

January markup isn’t the finish line — the CLARITY Act still leaves DeFi rules dangerously vague, risking a collapse of retail protections
A January 2026 markup of the CLARITY Act opens the next stage of a fight that could hollow out retail safeguards. The…

Integer Shareholders Offered Spot to Lead Fraud Case — What Investors Need to Know Now
Rosen Law Firm says purchasers of Integer (ITGR) between July 25, 2024 and October 22, 2025 may seek lead-plaintiff…

StubHub Investors Get a Deadline Notice as a Securities Suit Moves Forward — What Shareholders Need to Know
Kessler Topaz has alerted StubHub (STUB) shareholders to an upcoming deadline to join a securities class action. This…